In response to continued interest from our members in pharmacy benefit and prescription drug trends, The Council is partnering with McKinsey to conduct a survey on emerging products, solutions, benefit
The employee benefits market is a model for innovation.
The changing landscape is creating an opportunity to transform not only how consumers receive and understand their healthcare, but how they use and pay for that care.
From passage of the ACA to the injection of digital health and technology companies into the ecosystem, the industry is grappling with how to improve the health of employee populations, while decreasing healthcare costs for employers.
In a world where transparency and innovation meet cost and regulatory challenges, employee benefits consultants must remain agile.
Pricing Transparency
Clarity in the marketplace.
Payment Reform
The intersection of cost and quality of care.
Healthcare Data and Tech
What is changing and how.
The Council of Employee Benefits Executives (CEBE) Advisory Committee
The Council of Employee Benefits Executives Advisory Committee is a standing committee of The Council and represents the benefits business interests of The Council member firms.
All Healthcare Items
June 24, 2022 The Supreme Court overturned Roe v. Wade today in a 6-3 decision. The Court’s full, 215-page opinion is available here. Our team is working through the details and impact,
March 8, 2021 With the Saturday passage in the Senate (on a 50-49 party-line vote) of a $1.9 trillion American Rescue Plan Act, Congress is on track to complete the
March 2, 2021 To support the broader health and wellbeing of our colleagues and our communities, The Council has taken two steps to support the broader health and wellbeing of
March 1, 2021 On February 26, 2021, the Center for Medicare and Medicaid Services (CMS) issued additional guidance regarding coverage of COVID-19 vaccines and testing for group health plans (including
January 15, 2021 The following alert is from The Council’s government affairs team. Yesterday afternoon, the incoming Biden Administration released the outline of a $1.9 trillion COVID-19 relief package that
The Council’s initial thoughts on the potential brokerage impact of potential full upcoming Democratic control of the executive and legislative branches.
After nearly a week of threats to veto the $2.3 trillion omnibus/relief bill, President Trump signed it into law.
Federal government funding runs out at midnight tonight, and is unclear whether the House and the Senate can act on a catch-all funding measure as well as pandemic relief.
Much is at risk, including a revised PPP plan, as well as potential major provisions on surprise medical billing.